Introduction to Pharmacoeconomics
-
Conferences
- Upcoming Conferences
- Past Conferences
- Register
- Abstract Information
- Submit Abstract
- Exhibits & Sponsorships
- Awards & Grants
- Recent Conferences
-
Education & Training
- Short Courses
-
Webinars
- Economic evaluation of vaccination programs
- Patient-Preference Information – What It Is and What It Is Not
- 2020 Top 10 HEOR Trends
- Adding Depth to Observational Research through Data Linkage
- New Developments of Health Technology Assessment in Asia Pacific
- Financing Epidemics: Developing an Insurance Scheme for Outbreaks in Africa
- Why and How to Use Qualitative Research Methods in Conjunction with Discrete Choice Experiments in Healthcare
- Patient Reported Outcomes in Asia Pacific: Opportunity and Challenges
- Patient Engagement in Research: An ISPOR Definition
- Assessing the Impacts of a Pandemic on Pharmaceutical and Medical Device Utilization
- Health Technology Assessment Training
-
Sponsored Webinars
Faculty
Course Description
This module is an introduction to the role of pharmacoeconomics (PE) in medical decision making from multiple perspectives. It will introduce the concepts of types of PE/Cost-effectiveness analysis (CEA), general computation involved in these analyses, and how to evaluate a CEA.
Learning Objectives
By the end of the Introduction to Pharmacoeconomics (PE) module, you will be able to:
- State the role of PE in medical decision making.
- Define the types of PE/cost-effectiveness analyses (CEA).
- Explain the societal, patient and payer tradeoffs involved in using PE for medical decision making.
- Understand the difference between and usefulness of average and incremental (marginal) CEA.
- State the definition of utility measurement and its use in cost-utility analysis.
- Understand the elements essential to a published CEA.